Literature DB >> 24235917

Proposed guidelines for the management of nodding syndrome.

R Idro1, K A Musubire, B Byamah Mutamba, H Namusoke, J Muron, C Abbo, R Oriyabuzu, J Ssekyewa, C Okot, D Mwaka, P Ssebadduka, I Makumbi, B Opar, J R Aceng, A K Mbonye.   

Abstract

Nodding Syndrome is a poorly understood neurologic disorder of unknown aetiology that affects children and adolescents in Africa. Recent studies have suggested that the head nods are due to atonic seizures and Nodding Syndrome may be classified as probably symptomatic generalised epilepsy. As part of the Ugandan Ministry of Health clinical management response, a multidisciplinary team developed a manual to guide the training of health workers with knowledge and skills to manage the patients. In the absence of a known cause, it was decided to offer symptomatic care. The objective is to relieve symptoms, offer primary and secondary prevention for disability and rehabilitation to improve function. Initial management focuses on the most urgent needs of the patient and the immediate family until 'stability' is achieved. The most important needs were considered as seizure control, management of behavioural and psychiatric difficulties, nursing care, nutritional and subsequently, physical and cognitive rehabilitation. This paper summarises the processes by which the proposed guidelines were developed and provides an outline of the specific treatments currently being provided for the patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24235917      PMCID: PMC3824512          DOI: 10.4314/ahs.v13i2.4

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  35 in total

1.  Nodding disease: mystery of southern Sudan.

Authors:  Marc Lacey
Journal:  Lancet Neurol       Date:  2003-12       Impact factor: 44.182

2.  Endemic epilepsy in an isolated region of Liberia.

Authors:  J Goudsmit; F W van der Waals
Journal:  Lancet       Date:  1983-03-05       Impact factor: 79.321

3.  Some biochemical observations in the Nakalanga.

Authors:  P J Leonard; J P Stanfield
Journal:  East Afr Med J       Date:  1965-12

4.  Opinion statement on the minimal acceptable standards of healthcare in cerebral palsy.

Authors:  A M Bakheit; E Bower; A Cosgrove; M Fox; R Morton; S Phillips; D Scrutton; V Shrubb; C Yude
Journal:  Disabil Rehabil       Date:  2001-09-10       Impact factor: 3.033

5.  Improvements in physical fitness of Kenyan schoolboys infected with hookworm, Trichuris trichiura and Ascaris lumbricoides following a single dose of albendazole.

Authors:  L S Stephenson; M C Latham; S N Kinoti; K M Kurz; H Brigham
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Mar-Apr       Impact factor: 2.184

6.  Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.

Authors:  Jerry R McKee; Theodore R Sunder; Alain Vuong; Ann E Hammer
Journal:  J Child Neurol       Date:  2006-05       Impact factor: 1.987

Review 7.  Valproate as a mainstay of therapy for pediatric epilepsy.

Authors:  Renzo Guerrini
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

8.  Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy.

Authors:  Frank J Vajda; Terence J O'brien; Alison Hitchcock; Janet Graham; Mark Cook; Cecilie Lander; Mervyn J Eadie
Journal:  J Clin Neurosci       Date:  2004-11       Impact factor: 1.961

9.  Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study.

Authors:  Petra M C Callenbach; Willem Frans M Arts; Robert ten Houten; Paul Augustijn; W Boudewijn Gunning; Els A J Peeters; Alma M Weber; Hans Stroink; Yvette Geerts; Ada T Geerts; Oebele F Brouwer
Journal:  Eur J Paediatr Neurol       Date:  2007-10-18       Impact factor: 3.140

Review 10.  Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.

Authors:  Emilio Perucca
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

View more
  26 in total

1.  Nodding syndrome, infections and sexuality.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2013-06       Impact factor: 0.927

2.  Nodding syndrome, western Uganda, 1994.

Authors:  Christoph Kaiser; Tom Rubaale; Ephraim Tukesiga; Walter Kipp; George Asaba
Journal:  Am J Trop Med Hyg       Date:  2015-04-27       Impact factor: 2.345

3.  Psychological treatments delivered by community health workers in low-resource government health systems: effectiveness of group interpersonal psychotherapy for caregivers of children affected by nodding syndrome in Uganda.

Authors:  Byamah B Mutamba; Jeremy C Kane; Joop T V M de Jong; James Okello; Seggane Musisi; Brandon A Kohrt
Journal:  Psychol Med       Date:  2018-02-15       Impact factor: 7.723

4.  Systemic and cerebrospinal fluid immune and complement activation in Ugandan children and adolescents with long-standing nodding syndrome: A case-control study.

Authors:  Rodney Ogwang; Dennis Muhanguzi; Kioko Mwikali; Ronald Anguzu; Joe Kubofcik; Thomas B Nutman; Mark Taylor; Charles R Newton; Angela Vincent; Andrea L Conroy; Kevin Marsh; Richard Idro
Journal:  Epilepsia Open       Date:  2021-03-12

5.  Is the glass half full or half empty? A qualitative exploration on treatment practices and perceived barriers to biomedical care for patients with nodding syndrome in post-conflict northern Uganda.

Authors:  Amos Deogratius Mwaka; Elialilia S Okello; Catherine Abbo; Francis Okot Odwong; Willy Olango; John Wilson Etolu; Rachel Oriyabuzu; David Kitara Lagoro; Byamah Brian Mutamba; Richard Idro; Bernard Toliva Opar; Jane Ruth Aceng; Assuman Lukwago; Stella Neema
Journal:  BMC Res Notes       Date:  2015-08-29

6.  Physical growth, puberty and hormones in adolescents with Nodding Syndrome; a pilot study.

Authors:  Theresa Piloya-Were; Beatrice Odongkara-Mpora; Hanifa Namusoke; Richard Idro
Journal:  BMC Res Notes       Date:  2014-11-28

7.  Patients with nodding syndrome in Uganda improve with symptomatic treatment: a cross-sectional study.

Authors:  Richard Idro; Hanifa Namusoke; Catherine Abbo; Byamah B Mutamba; Angelina Kakooza-Mwesige; Robert O Opoka; Abdu K Musubire; Amos D Mwaka; Bernard T Opar
Journal:  BMJ Open       Date:  2014-11-14       Impact factor: 2.692

8.  Health Seeking Behaviours among Caretakers of Children with Nodding Syndrome in Pader District - Northern Uganda: A Mixed Methods Study.

Authors:  Pamela Atim; Emmanuel Ochola; Stephen Ssendagire; Elizeus Rutebemberwa
Journal:  PLoS One       Date:  2016-07-29       Impact factor: 3.240

9.  Paroxysmal head drops with ataxia-like symptoms presenting as Sandifer syndrome in a 3-year old girl.

Authors:  Abubakar Sharif; Lucinda Carr; Efstratios Saliakellis; Himadri Chakraborty
Journal:  BMJ Case Rep       Date:  2020-03-04

10.  Nodding syndrome and epilepsy in onchocerciasis endemic regions: comparing preliminary observations from South Sudan and the Democratic Republic of the Congo with data from Uganda.

Authors:  Robert Colebunders; Adam Hendy; John L Mokili; Joseph Francis Wamala; Joice Kaducu; Lucia Kur; Floribert Tepage; Michel Mandro; Gisele Mucinya; Germain Mambandu; Michel Yendema Komba; Jean Louis Lumaliza; Marieke van Oijen; Anne Laudisoit
Journal:  BMC Res Notes       Date:  2016-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.